Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5024 rosacea relapse follow-up study
2006-003156-37Phase 2Completed
- Sponsor
- Galderma
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ivermectin, metronidazole and vehicle in papulopustular rosacea and rosacea (3 arms), sponsored by Galderma. Primary endpoint: Time to relapse. Started Aug 2006; status: completed.
02
Drugs
ivermectinmetronidazolevehicle
03
Conditions
papulopustular rosacearosacea
Beyond the preview
Go deeper on 2006-003156-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003156-37.